Mgmt promoter methylation as a prognostic factor in primary glioblastoma: a single-institution observational study

HIGHLIGHTS

• who: Mateusz Szylberg et al. from the Department of Neurosurgery and Neurology, Jan Biziel University Hospital Nr, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland have published the Article: MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study, in the Journal: Biomedicines 2022, 10, 2030. of /2022/
• what: The aim of this study was to assess the prognostic significance of MGMT promoter methylation and its associations with clinical variables.
• how: The flow chart of the study is presented in Figure 1. In the following years a significant number . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.